ADHD

Gambling

Opioid Related Disorders

Alcohol Abuse

Amphetamine Related Disorders

Substance Use Disorder

Addiction & Substance Use

Alzheimer Disease

Disaster Psychiatry

Panic Disorder

Trauma And Violence

Traumatic Stress Disorders

Anxiety & Stress Disorders

Mania

Bipolar Disorder

COVID-19

Cannabis

Case Discussions

Child & Adolescent Psychiatry

Climate Change

Comorbidity

Compulsive Disorders

Cultural Psychiatry

Digital Therapeutics

Diversity, Equity, Inclusion

Drug Watch

Eating Disorders

Emergency Psychiatry

Ethics

Munchausen Syndrome

Sexual Offenses

Forensic Psychiatry

Geriatric Psychiatry

Integrative Psychiatry

Major Depressive Disorder

Media & Psychiatry

Mental Health Awareness Month

Mood Disorders

Cognitive Disorders

Dementia

Autism

Neuropsychiatry

PTSD

Compulsive Personality Disorder

Dependent Personality Disorder

Dissociative Identity Disorder

Histrionic Personality Disorder

Schizoid Personality Disorder

Antisocial Personality Disorder

Borderline Personality

Personality Disorders

Postpartum Depression

Psychedelics

Psychopharmacology

Delirium

Metabolic Disorders

Somatoform Disorder

Psychosomatics

Cognitive Behavioral Therapy

Psychotherapy

Paranoid Schizophrenia

Psychotic Affective Disorders

Schizoaffective

Schizophrenia Psychotic Features

Schizotypal Personality Disorder

Catatonic Schizophrenia

Schizophrenia/Psychosis

Nocturnal Paroxysmal Dystonia

Sleep Deprivation

Sleep Wake Transition

Circadian Rhythm Sleep Disorders

Sleep Disorders

Pervasive Developmental Disorder

Gender Issues

Military Mental Health

Special Populations

Sports Psychiatry

Suicide

Tardive Dyskinesia

Technology & Psychiatry

Transcranial Magnetic Stimulation

News

Media

Around the Practice

Between the Lines

PsychView

Expert Perspectives

Case-Based Psych Perspectives

Clinical Case Collective

Dialogues

Payer-Provider Perspective

Slideshows

Videos

Viewpoints

Conferences

Conference Coverage

Conference Listing

Publication

Psychiatric Times

Job Board

CME/CE

Partners

Editorial

Resources

Clinical Consult

Clinical Scales

Interactive Tools

Partner Perspectives

Quizzes

Series

Special Reports

Subscribe

Articles

Check out the pipeline updates from April!

April in Review: Updates on the Psychiatric Treatment Pipeline

is a sports psychiatrist in Los Angeles, California, and CEO of WCM Sports Psych. She is an advocate and educator on the intersection of mental health, sports, and racial and social justice. Dr Charles Malveaux lends her expertise as a psychiatric consultant to multiple national sport-related agencies, professional sports teams, and organizations. She served for over 4 years as the Western Regional Trustee (region 4) on the Board of Black Psychiatrists of America. Dr Charles Malveaux now serves on the Board of Directors for the American Board of Sports and Performance Psychiatry (ABSPP), as well as on advisory boards for organizations serving the community.

Top 3 Studies on Athletes' Mental Health From Around the Globe: Insights from Q1 2025

2025: a big year for emergency psychiatry. Don't miss any of our Special Report articles!

April’s Special Report: Emergency Psychiatry

A groundbreaking study explores innovative neuroassessment technology to enhance understanding and treatment of borderline personality disorder symptoms.

First-of-its-Kind Study: Using a Novel Platform to Assess Patients With Borderline Personality Disorder

About

Advertise

Contact Us

Terms and Conditions

Privacy Policy

Do Not Sell My Personal Information

Facebook

LinkedIn

Spotlight

Expanding Possibilities in MDD: Exploring Rapid-Acting Therapeutic Options

Commentary

Couch In Crisis

Early Career Psychiatry

History of Psychiatry

Residents Corner

Cultural Corner

Film and Book Reviews

Poetry

Writers Contest

Psychiatric Practice

Burnout

Careers

Coding

Guidelines

Risk Management

Telepsychiatry

Critical Conversations in Psychiatry

Portraits

Psychiatric Views on the Daily News

Tales from the New Asylum

An engaging video series showcasing a high-level, conversational discussion between 2 prominent clinicians that raises awareness and drives education on important psychiatric topics.

Explore compelling commentary and insights as industry experts discuss vital topics, with key takeaways on how to implement findings into practice.


1rem

Gus Alva, MD discusses how he will be examining notable challenges in schizophrenia care, including access issues, and exploring the potential role of prescription digital therapeutics in addressing these gaps.

The Role of Prescription Digital Therapeutics in the Schizophrenia Treatment Landscape